Therapeutic Vaccines Market Flourishing To End On USD 47.44 Billion by 2022

25-Sep-2018 | Zion Market Research

Some of the major companies in therapeutic vaccines market comprise BioVex, Inc., Valeant Pharmaceuticals, Immunocellular Therapeutics, Ltd., Inovio Pharmaceuticals, Inc., GlaxoSmithKline plc., Agenus Inc., Novartis AG, Argos Therapeutics, Pfizer Inc., Transgene, Bavarian Nordic, Vaccinogen, Inc., and Galena Biopharma among others. These players are set to bolster the therapeutic vaccines market.

As per analysts at Zion Market Research, global therapeutic vaccines market was capitalized at almost USD 10.54 Billion in 2016 and is likely to create income of almost USD 47.44 Billion by 2022, developing at a CAGR of almost 28.5% from 2017 to 2022.

Request Sample Request Customization Buy Now

This review is based on a report by Zion Market Research, titled “Therapeutic Vaccines Market by Products (Addiction Vaccines, Autoimmune Disease Vaccines, Infectious Disease Vaccines and Neurological Disease Vaccines) and by Technology (Autologous Vaccine and Allogeneic Vaccine): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2016 - 2022”- Report at

Growing Funds From The Government For R&D Of Vaccines Is Set To Augment The Development Of Global Therapeutic Vaccines Market

Global therapeutic vaccines market is majorly fostered by increasing occurrences of chronic diseases such as HIV and cancer all over the globe, as per analysts at Zion Market Research. Other major boosting factors for therapeutic vaccines market are growing funds from the government for R&D of vaccines paired with technological advancements. For example, in April 2018, the Four-strain vaccine Influvac Tetra (dubbed as a quadrivalent vaccine,) developed by Mylan was made available in New Zealand.


On the other hand, stringent regulatory policies and high cost of treatment paired with high capital investment at the beginning are the major limitations that may hinder the development of the therapeutic vaccines market. Nonetheless rising focus on customized medicine paired with the requirement for effective therapy are expected to reveal the new opportunities for development therapeutic vaccines market in the forecast period. In addition to this, elevating job opportunities is also set to foster the development of therapeutic vaccines market.

Autoimmune Disease Vaccine To Develop At Quickest Rate In The Therapeutic Vaccines Market In The Near Future

Based on product type, the therapeutic vaccines market is divided as autoimmune disease vaccines, addiction vaccines, neurological disease vaccines, and infectious disease vaccines. Autoimmune disease vaccine section is likely to develop at quickest rate in the therapeutic vaccines market in the near future. The therapeutic vaccines market is divided on the basis technology into allogeneic vaccines and autologous vaccines.

North America Likely To Stay The Dominating Area In The Therapeutic Vaccines Market In The Near Future

Europe, North America, Latin America, Asia-Pacific, and Middle East & Africa are major areas of global therapeutic vaccines market. North America is likely to stay the dominating area in the near future. It will be followed by Europe. Requirement for therapeutic vaccines was uppermost in North America particularly in the U.S. Asia Pacific is likely to be the moderate developing area during the forecast period in therapeutic vaccines market. Furthermore, Latin America and the Middle East & Africa are also likely to show reasonable development for therapeutic vaccines market in the coming years.

The global therapeutic vaccines market is segmented as follows:

By Product

  • Addiction Vaccines
  • Autoimmune Disease Vaccines
  • Infectious Disease Vaccines
  • Neurological Disease Vaccines

By Technology

  • Autologous vaccines 
  • Allogeneic vaccines

By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651

Download Brochure
Latest Published Reports

View All Published Reports